iShares US Pharmaceuticals ETF
IHE
IHE
92 hedge funds and large institutions have $276M invested in iShares US Pharmaceuticals ETF in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
10% more funds holding
Funds holding: 84 → 92 (+8)
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
63% less call options, than puts
Call options by funds: $537K | Put options by funds: $1.47M
Holders
92
Holding in Top 10
2
Calls
$537K
Puts
$1.47M
Top Buyers
| 1 | +$64.3M | |
| 2 | +$18.7M | |
| 3 | +$15.6M | |
| 4 |
Morgan Stanley
New York
|
+$9.48M |
| 5 |
RTS
Round Table Services
Westfield,
New Jersey
|
+$6.86M |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$4.25M | |
| 3 | -$1.88M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.7M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$1.08M |